Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 17Solid Tumor 7Advanced Solid Tumors 5Locally Advanced or Metastatic Solid Tumors 2Solid Tumor, Adult 1Mesothelioma, Malignant 1DMMR Colorectal Cancer 1Advanced Solid Tumours 1Advanced Malignant Solid Tumors 1

Interventions

pembrolizumab 7Radiotherapy 3Proton Therapy 3Interleukin-2 3Cyclophosphamide 3spartalizumab 2fludarabine 2Rosuvastatin Calcium 2Paclitaxel 2Ipilimumab 2Immune Checkpoint Inhibitors 2Cetuximab 2Carboplatin 2Blood Specimen Collection 2toripalimab 1tislelizumab 1sotorasib 1peposertib 1pazopanib 1patritumab deruxtecan 1palbociclib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1leronlimab 1lenvatinib 1atezolizumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor, Adult × toripalimab × Other solid neoplasm × Clear all
NCT06088004 2025-08-22

Phase â… /â…¡ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Suzhou Abogen Biosciences Co., Ltd.

Phase 1/2 Recruiting
218 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡